Skip to main content
Back to Top
Toggle navigation
ASHP
ASHP
Toggle navigation
Login
Join ASHP
yourpharmacist.org
ASHP Foundation
About ASHP
Store
AJHP
Practice Resources
Drug Shortages
Products and Services
Pharmacy Practice
Featured Practice Areas
Resource Centers
ASHP Accreditation Programs
Guidelines (Positions & Statements)
Consulting Service
ASHP Certified Center of Excellence
PAI 2030
Professional Development
Professional Development
Continuing Education
Competency Assessments
CareerPharm
ASHP Podcasts
Residency Information
Student Information
Technician Information
Board Certification Resources
ASHP Professional Certificates℠
ASHP Training Programs
ASHP Microcredentials
Certified Pharmacy Executive Leader (CPEL)
Claim Your CE
Meetings & Conferences
Meetings and Conferences
Midyear Clinical Meeting and Exhibition
NEW! Pharmacy Futures
Residency Program Design and Conduct Workshops
Live Pharmacotherapy Review and Recertification Course
National Pharmacy Preceptors Conference
ASHP Conference for Pharmacy Leaders
Get Involved in a Meeting
Advocacy
Advocacy
Grassroots Network
Key Issues
ASHP-PAC
Member Center
Member Information
Get Involved in ASHP
My ASHP
ASHP Connect
House of Delegates
Awards
Sections & Forums
Welcome to ASHP Navigator
Home
Policy Positions and Guidelines
1804
Add To Favorites
Share
Print
ASHP Policy Position 1804
DRUG DOSING IN CONDITIONS THAT MODIFY PHARMACOKINETICS OR PHARMACODYNAMICS (Superseded)
Status: Superseded
This policy position supersedes ASHP policy position
1720
.
Superseded by ASHP policy position
2606
.
Midyear Clinical Meeting 2022
Match Day Resources
continuing education
drug shortages
policy positions and guidelines
residency
for presenters
get involved in a meeting
